Seattle Genetics, Inc.

NASDAQ: SGEN
$178.33
+$2.52 (+1.4%)
Closing price August 8, 2022
24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top exchange-traded funds for a breakdown of what they own to show how much they are lagging...
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Chipotle Mexican Grill, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre and U.S....
Seattle Genetics shares dipped on Monday following an update from the FDA on Adcetris for certain lymphomas.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Analog Devices, Halliburton, Neovasc, Nike, NXP Semiconductors, PepsiCo, Skyworks Solutions and Whiting Petroleum.
Monday's s analysts upgrades and downgrades include Altria, Match Group, ConocoPhillips, Seattle Genetics, SunPower Corporation, and more.
The top analyst upgrades, downgrades and other research calls from Tuesday include AK Steel, BHP Billiton, Dominion Energy, JB Hunt, KLA-Tencor, Micron Technology, Nucor, Oracle, Roku and U.S. Steel.
Cascadian Therapeutics saw its shares absolutely skyrocket on Wednesday after it was announced that Seattle Genetics would be acquiring the company. This is far and away the top-performing stock in...
The top analyst upgrades, downgrades and other research calls from Friday include Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal and Stratasys.
Some of the top biotech stocks could become extremely volatile before and after earnings. These four that may be worth a look for aggressive investors.
Immunomedics watched its shares make a massive gain on Friday after the company announced the termination of its licensing deal with Seattle Genetics.
2017 could be different for the health care sector. It is very possible that this new administration could lead to more positive trials, FDA approvals, and mergers and acquisitions.
Seattle Genetics shares were down double-digits after the company announced that the FDA has placed holds on several early-stage clinical trials of its leukemia drug candidate.
Monday’s top analyst upgrades, downgrades and initiations include Advanced Micro Devices, CVS Health, ConocoPhillips, EOG Resources, Seattle Genetics and WebMD.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include AK Steel, Celgene, Darden Restaurants, Delphi Automotive, Johnson & Johnson and U.S. Steel.
After a dramatic conclusion to the presidential race, insider buying was dramatically larger than we have seen in months, and it could continue the rest of the year.